Mycobacterium indicus pranii therapy induces tumor regression in MyD88- and TLR2-dependent manner

OBJECTIVES: Mycobacterium indicus pranii (MIP) is an atypical mycobacterium species with potent antitumor efficacy. Macrophages and dendritic cells (DCs) are antigen-presenting cells, playing key roles in the activation of antitumor immunity. We have previously shown the potent activation of macroph...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Pawan, Das, Gobardhan, Bhaskar, Sangeeta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781299/
https://www.ncbi.nlm.nih.gov/pubmed/31590685
http://dx.doi.org/10.1186/s13104-019-4679-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781299/
https://www.ncbi.nlm.nih.gov/pubmed/31590685
http://dx.doi.org/10.1186/s13104-019-4679-0

Ejemplares similares